Oncology and Hematology
Oncology and Hematology Clinical Practice
Stay current with Oncology and Hematology education that fits how you practice. ReachMD offers practical, on-demand clinical content for oncologists, hematologists, oncology nurses, pharmacists, fellows, APPs, and the full cancer care team. Explore expert discussions, case-based programs, CME/CE opportunities, industry features, and news across solid tumors, hematologic malignancies, biomarker-driven care, immunotherapy, targeted therapy, supportive care, and more.
Use this page to find relevant oncology and hematology content fast. Browse Project Oncology episodes, jump into CME/CE activities, review expert perspectives, or explore timely updates on evolving treatment strategies and standards of care. New content is added regularly, so you can stay current with emerging evidence, guideline updates, and multidisciplinary approaches to cancer care on your schedule.
Start with the latest programs below or browse by content type to find the Oncology and Hematology education most relevant to your practice.
151-165 of 339
Risk Stratification and Patient Selection for Perioperative ICIs
MinuteCE®Risk Stratification and Patient Selection for Perioperative ICIs
Douglas Adkins, MD
Next-Generation Innovations: The Future of CELMoDs in Myeloma
MinuteCE®Next-Generation Innovations: The Future of CELMoDs in Myeloma
Noopur Raje, MD
Joshua Richter, MD
Sagar Lonial, MD, FACP
Noopur Raje, MD
Safety First: Navigating CELMoD-Associated Toxicities
MinuteCE®Safety First: Navigating CELMoD-Associated Toxicities
Joshua Richter, MD
Noopur Raje, MD
Mastering the Sequence: CELMoDs Across Treatment Lines
MinuteCE®Mastering the Sequence: CELMoDs Across Treatment Lines
Sagar Lonial, MD, FACP
Noopur Raje, MD
Case Application: Frontline Insights—Tackling Newly Diagnosed Myeloma
MinuteCE®Case Application: Frontline Insights—Tackling Newly Diagnosed Myeloma
Joshua Richter, MD
Noopur Raje, MD
- advertisement
Real-World Ready: Practical Tips for Community Oncologists
MinuteCE®Real-World Ready: Practical Tips for Community Oncologists
Joshua Richter, MD
Sagar Lonial, MD, FACP
Sagar Lonial, MD, FACP
Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
MinuteCE®Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
Joshua Richter, MD
Sagar Lonial, MD, FACP
Sagar Lonial, MD, FACP
Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
MinuteCE®Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
Sapna Patel, MD
John M. Kirkwood, MD
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
MinuteCE®Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
Hussein Tawbi, MD, PhD
Sapna Patel, MD
- advertisement
Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma
MinuteCE®Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma
John M. Kirkwood, MD
Sapna Patel, MD
Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
MinuteCE®Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
Hussein Tawbi, MD, PhD
Paolo A. Ascierto, MD
Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
MinuteCE®Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
John M. Kirkwood, MD
Sapna Patel, MD
